Focal Atrial Tachycardia¶
Chapter 255 | Part 12: Endocrinology
KEY CLINICAL POINTS¶
- Focal atrial tachycardia (AT) is an arrhythmia originating from a single focus in the atrium, distinct from AV nodal reentry or accessory pathway-mediated SVTs.
- Differentiation from POTS and inappropriate sinus tachycardia is critical, as treatment strategies differ significantly.
- ECG features include discrete P waves with isoelectric segments, 1:1 AV conduction, and characteristic P-wave morphology reflecting the atrial focus location.
- Treatment depends on symptom severity, with catheter ablation being the definitive therapy for symptomatic cases.
- Digitalis toxicity and atrial fibrosis are important associations with AT, particularly with AV block patterns.
1. DEFINITION & OVERVIEW¶
Focal atrial tachycardia (AT) is an arrhythmia characterized by rapid, regular atrial activation originating from a single focus in diseased atrial tissue. It differs from typical atrial flutter and AV nodal reentry by its localized origin and distinct electrophysiologic mechanisms. AT can be sustained, nonsustained, paroxysmal, or incessant, and accounts for ~10% of paroxysmal supraventricular tachycardias (PSVTs) in patients referred for catheter ablation.
Mechanisms of Paroxysmal Supraventricular Tachycardia¶
| Mechanism | R-P Relationship | ECG Features | Key Differentiators |
|---|---|---|---|
| AV Node Reentry (AVNRT) | RRPP << PPRR | P waves may merge with QRS | Depends on AV nodal conduction |
| AV Reentry with Accessory Pathway (AVRT) | RRPP >> PPRR | Delta waves present | Depends on accessory pathway |
| Focal Atrial Tachycardia (AT) | 1:1 AV conduction or AV block | Discrete P waves with isoelectric segments | Localized atrial focus |
1.1 Mechanisms¶
AT arises from abnormal automaticity, triggered automaticity, or small reentry circuits in diseased atrial tissue. Fibrosis from prior ablations or conditions like atrial fibrillation can create substrates for focal activation. Sympathetic stimulation and drug toxicity (e.g., digitalis) may precipitate episodes.
1.2 Clinical Presentation¶
Symptoms vary but often mimic other supraventricular tachycardias (SVTs). Incessant AT may lead to tachycardia-induced cardiomyopathy. P waves are discrete with isoelectric segments, distinguishing it from atrial flutter and macroreentrant AT.
2. EPIDEMIOLOGY¶
Focal AT accounts for ~10% of paroxysmal supraventricular tachycardias (PSVTs) in patients referred for catheter ablation. Nonsustained AT is common on ambulatory ECG monitoring, with prevalence increasing with age. Asymptomatic cases are often labeled as 'SVT' on monitors, prompting unnecessary ablation consideration.
2.1 Risk Factors¶
Atrial fibrosis from prior ablations, atrial structural disease, and sympathetic overactivity increase risk. Digitalis toxicity and electrolyte imbalances may precipitate episodes.
3. ETIOLOGY & PATHOPHYSIOLOGY¶
AT arises from abnormal automaticity in diseased atrial tissue, often with fibrosis from prior ablations or conditions like atrial fibrillation. Fibrotic areas create substrates for microreentry or abnormal automaticity. Sympathetic stimulation and drug toxicity (e.g., digitalis) may exacerbate or trigger episodes.
3.1 Molecular Basis¶
Diseased atrial tissue exhibits altered ion channel function, leading to increased automaticity. Fibrosis disrupts normal conduction, creating zones of slow conduction that facilitate reentry.
4. CLINICAL FEATURES¶
Symptoms are variable but often include palpitations, chest discomfort, and dyspnea. Incessant AT may cause tachycardia-induced cardiomyopathy. ECG findings include 1:1 AV conduction, discrete P waves with isoelectric segments, and characteristic P-wave morphology reflecting the atrial focus location.
4.1 P-Wave Morphology¶
P-wave morphology varies by origin: narrow in septal origins, monophasic positive in lead V1 for left atrial foci, and positive in inferior leads for superior vena cava origins. P waves resembling sinus tachycardia may occur with crista terminalis foci.
5. DIFFERENTIAL DIAGNOSIS¶
Differentiate from inappropriate sinus tachycardia (P waves mimic sinus rhythm), postural orthostatic tachycardia syndrome (POTS), and AV nodal reentry. AT is distinguished by discrete P waves, lack of AV nodal dependency, and characteristic P-wave morphology.
5.1 Key Differentiators¶
AT lacks AV nodal dependency, with P waves not terminating with AV block. P waves in AT are discrete with isoelectric segments, unlike sinus tachycardia. Incessant AT may mimic atrial flutter but lacks the sawtooth morphology.
6. INVESTIGATIONS & DIAGNOSIS¶
Diagnosis relies on ECG findings: discrete P waves with isoelectric segments, 1:1 AV conduction, and characteristic P-wave morphology. Holter monitoring identifies asymptomatic nonsustained AT. Electrophysiologic studies may confirm the mechanism.
6.1 Diagnostic Criteria¶
ECG criteria include discrete P waves with isoelectric segments, 1:1 AV conduction, and absence of AV nodal dependency. Incessant AT may show tachycardia-induced cardiomyopathy on echocardiogram.
7. MANAGEMENT & TREATMENT¶
Asymptomatic nonsustained AT requires no treatment. Symptomatic cases are managed with rate control, antiarrhythmics (e.g., beta-blockers, calcium channel blockers), and catheter ablation. Digitalis toxicity requires discontinuation and antidotal therapy.
7.1 Treatment Algorithm¶
- Confirm diagnosis via ECG and Holter monitoring.
- Rate control with beta-blockers or calcium channel blockers.
- Consider catheter ablation for symptomatic or incessant AT.
- Discontinue digitalis and correct electrolyte imbalances in toxic cases.
8. PROGNOSIS & COMPLICATIONS¶
Prognosis is generally favorable, but incessant AT may lead to tachycardia-induced cardiomyopathy. Complications include hemodynamic instability, syncope, and progression to atrial fibrillation. Digitalis toxicity may cause AV block patterns with AT.
9. SPECIAL CONSIDERATIONS¶
In digitalis toxicity, AT with AV block is characteristic. Asymptomatic nonsustained AT in elderly patients may require monitoring rather than intervention. Catheter ablation is preferred for symptomatic cases, with success rates >90% for localized foci.
10. KEY POINTS & CLINICAL PEARLS¶
- Differentiate AT from AV nodal reentry by lack of AV nodal dependency.
- P-wave morphology reflects the atrial focus location.
- Asymptomatic nonsustained AT requires no treatment.
- Catheter ablation is definitive therapy for symptomatic AT.
- Digitalis toxicity may present with AT and AV block.